STAT+: Pharmalittle: Genentech finds no evidence of fraud in paper by former top exec; FDA withdraws approval for premature-birth drug
And so, another working week will soon draw to a close. Not a moment too…
Category: Pharmalot
STAT+: Brazilian committee says a Vertex cystic fibrosis is not cost-effective and should not be reimbursed
A Brazilian government advisory committee recommended that the health ministry not pay for a cystic…
STAT+: FDA withdraws approval of controversial drug to prevent preterm births
After a years-long controversy, the U.S. Food and Drug Administration ordered the immediate withdrawal of a…
STAT+: Pharmalittle: Weight-loss drug ads pose new oversight challenge; will the new Bayer CEO split the company?
Rise and shine, another busy day is on the way. We can tell because the…
STAT+: Pharmalittle: J&J agrees to settle talcum powder claims for $8.9 billion; FDA authorizes new severe-Covid therapy
Good morning! Jason Mast here, filling in for Ed on this fine Passover eve. Every…
.jpg)
STAT+: ‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from Janssen
For the first time, Mark Cuban’s Cost Plus Drug Company is selling medicines made by…
STAT+: Pharmalittle: A ‘King Kong’ of weight-loss drugs is looming; FTC orders Illumina to divest Grail
Hello, everyone, and how are you today? We are doing just fine, thank you, since…
STAT+: Pharmalittle: FDA slams company recalling eye drops over manufacturing issues; U.S. funds massive Alzheimer’s research database
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: European Union drug pricing proposal for the pandemic treaty generates pushback
Amid treaty talks to create equitable access to medical products during pandemics, the European Union…
STAT+: Inflation caused a sizable drop in net drug prices in late 2022, analysis finds
Amid ongoing debate over the cost of prescription medicines, a new analysis finds that brand-name…
STAT+: FDA report details problems at Global Pharma plant involved in eye drop recall
Global Pharma Healthcare, whose eye drops have been linked to dozens of serious reactions, failed…
STAT+: Pharmalittle: Judge blocks required ACA coverage for preventive care; Supreme Court urged to review skinny label case
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Solicitor General urges Supreme Court to review ‘skinny labeling’ and generic drug access
The U.S. solicitor general urged the U.S. Supreme Court to review a controversy over so-called…
STAT+: Pharmalittle: FDA approves over-the-counter Narcan; J&J exits the race for the first RSV vaccine
Rise and shine, another busy day is on the way. We can tell because the…
STAT+: Dutch health minister won’t cover a Gilead cancer drug due to the cost
In a rare move, the Dutch health ministry refused to provide coverage for a Gilead…
STAT+: NIH releases data showing more clinical trial sponsors are reporting results, but most miss deadlines
In response to mounting criticism, the National Institutes of Health published data that shows an…
STAT+: Pharmalittle: WHO may add obesity drugs to essential medicines list; monkey shortage may delay drug development
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Shortage of monkeys for early-stage research jeopardizes timelines for developing some drugs
A growing shortage of monkeys used for early-stage pharmaceutical research is causing concern that many…
STAT+: Pharmalittle: Ohio attorney general accuses PBMs of price fixing; how cost-effectiveness fight could hobble drug price negotiations
Top of the morning to you. Steely gray skies are hovering over the Pharmalot campus…
STAT+: Ohio attorney general accuses pharmacy benefit managers of drug price fixing
The Ohio attorney general filed a lawsuit on Monday accusing three large pharmacy benefit managers…
STAT+: Pharmalittle: FDA proposes more rigorous cancer drug trials for accelerated approval; insurers not covering obesity meds for kids
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: California judge deals GSK a setback as first Zantac lawsuit will now go to trial
In a setback to GSK, a California judge ruled that a consumer cleared a key…
STAT+: Pharmalittle: EU delays pharma legislation again; India cancels license for maker of cough syrup linked to deaths
And so, another working week will soon draw to a close. Not a moment too…
STAT+: J&J loses a patent battle in India over a crucial tuberculosis drug
In a defeat for Johnson & Johnson, the Indian patent office has rejected its bid…
STAT+: Pharmalittle: FDA panel backs conditional approval for Biogen ALS drug; pharma fights tactic for lowering specialty med costs
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Drugmakers push back on a clever tactic employers use to avoid paying for specialty medicines
In the face of rising drug prices, health plan sponsors have quietly used a clever,…
STAT+: Pharmalittle: U.K. regulator to streamline clinical trial approvals; NIH won’t seize patents to cut price of cancer drug
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: NIH rejects bid to cut a cancer drug’s price by sidestepping patents
In a long-awaited decision, the U.S. National Institutes of Health rejected a petition urging the…
STAT+: Patient groups balk at former AstraZeneca official negotiating U.K.-India free trade deal
More than 200 civil society and patient advocacy groups are urging the U.K. government to…
STAT+: Pharmalittle: FDA official wants to use accelerated approval for gene therapies; pharma asks Biden for tax breaks in the semiconductor package
Top of the morning to you, and a fine one it is. A bright, shiny…
STAT+: Senator calls for probe of conflict of interest on federal panel overseeing dietary guidelines
A U.S. lawmaker wants the federal government to probe potential conflicts of interest held by…
.jpg)
STAT+: Pharmalittle: Manufacturers say bird flu shots for humans can be made quickly; obesity guidelines for children disappoint
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Sanofi cuts price on a popular insulin by 78%; Califf criticizes insurers for doing too little on drug research
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Sanofi becomes the third leading insulin maker to lower list prices, cutting Lantus price by 78%
Following the lead of its rivals, Sanofi will cut the price of its most widely…
STAT+: Here’s why there aren’t many cheap, generic versions of pricey inhalers
U.S. regulators approved dozens of inhalers to treat asthma and chronic obstructive pulmonary disease over…
STAT+: Pharmalittle: Alzheimer’s group starts lobbying for Medicare to cover new drug; U.S. judge seems sympathetic to abortion-pill challenge
Good morning, everyone, and how are you today? Hazy skies are enveloping the frosty Pharmalot…
STAT+: U.K. trade group suspends Novo Nordisk for ‘serious breaches’ in promoting obesity drug
In a rare move, a U.K. pharmaceutical industry trade group suspended Novo Nordisk for two…
STAT+: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Democratic lawmakers press pharmacy chains on abortion pill access
More than a dozen Democratic lawmakers are urging some of the nation’s largest drugstore chains…
STAT+: Pharmalittle: Novo to cut some insulin prices by up to 75%; Veterans Administration to cover new Alzheimer’s treatment
Rise and shine, everyone, another busy day is on the way. The Pharmalot campus, in…
STAT+: Novo Nordisk to lower insulin prices by up to 75% amid growing pressure
Under mounting pressure, Novo Nordisk plans to cut U.S. list prices for several insulin products…
STAT+: Veterans Health Administration will cover the newest Alzheimer’s drug
In an unexpected move, the Veterans Health Administration announced Monday that it will widely cover…
STAT+: Pharmalittle: Biogen exec who quarterbacked Aduhelm leaves; Pfizer to buy Seagen for $43 billion
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: New York officials press pharmacy chains over abortion pill; Sanders pushes bill for $20 insulin cap
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Insulin for $20 a vial? Sanders pushes bill for price caps on the diabetes treatment
Now that Eli Lilly is cutting prices on some of its insulin products, U.S. Sen….
STAT+: Pharmalittle: Pharmacies are battlegrounds in the abortion debate; Lilly Alzheimer’s drug failed to prevent memory loss in study
Rise and shine, folks, another busy day is on the way. Already, there was a…
STAT+: Pharmalittle: FDA head wants to get rid of advisory panel votes; premature-birth drug is finally withdrawn
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Controversial drug for premature birth is withdrawn by manufacturer after battle with FDA
After months of anticipation, the manufacturer of a controversial drug for premature births has agreed…
STAT+: Pharmalittle: Biden proposes expanding Medicare drug-price negotiation; Weight Watchers moves into obesity drug market
Top of the morning to you, and a fine one it is. Shiny and clear…
STAT+: Turkish court hands Novartis and Roche a rare win over their efforts to promote an eye treatment
A Turkish court overturned a decision by the national antitrust regulator that two years ago…